Member Engagement

Penrod partnered with a pharmaceutical company that manufactures treatments for rare bone cancer disorders in children, specifically related Fibrodysplasia Ossificans Progressiva (FOP). In order to maximize the reach of its treatments, our client needed robust insight into those suffering from FOP, and a process to refer them to high-quality physicians.